TRANSFUSION AND APHERESIS SCIENCE

Scope & Guideline

Advancing the Frontiers of Hematology and Transfusion Medicine

Introduction

Immerse yourself in the scholarly insights of TRANSFUSION AND APHERESIS SCIENCE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1473-0502
PublisherPERGAMON-ELSEVIER SCIENCE LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationTRANSFUS APHER SCI / Transfus. Apher. Sci.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTHE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND

Aims and Scopes

The journal 'Transfusion and Apheresis Science' primarily aims to advance the field of transfusion medicine and apheresis through the dissemination of high-quality research and clinical practice insights. It encompasses a broad range of topics related to blood transfusion, blood component therapy, apheresis techniques, and the underlying immunological and genetic factors influencing these processes.
  1. Transfusion Medicine:
    Focuses on the efficacy, safety, and clinical outcomes associated with blood transfusions, including studies on transfusion reactions, management of blood components, and the impact of transfusion on various patient populations.
  2. Apheresis Techniques:
    Explores advancements in apheresis technology, including therapeutic plasma exchange and stem cell collection, with an emphasis on optimizing protocols and improving patient outcomes.
  3. Immunohematology:
    Investigates immunological aspects of blood transfusion, including alloimmunization, blood group antigens, and the genetic factors influencing transfusion compatibility and patient responses.
  4. Clinical Applications:
    Provides insights into clinical practices and guidelines for managing patients requiring transfusion or apheresis, addressing specific conditions such as hemophilia, sickle cell disease, and other hematological disorders.
  5. Emerging Therapies and Technologies:
    Highlights innovative approaches to transfusion and apheresis, including the use of convalescent plasma, gene therapies, and novel anticoagulant treatments.
The journal has recently highlighted several emerging themes and trends that reflect the evolving landscape of transfusion medicine and apheresis. These themes indicate a proactive approach to addressing contemporary challenges and innovations in the field.
  1. COVID-19 Related Research:
    Numerous publications focus on the role of convalescent plasma and other blood products in treating COVID-19, indicating a significant trend towards understanding the implications of pandemics on transfusion practices.
  2. Personalized Medicine in Transfusion:
    An increasing interest in personalized approaches to transfusion and apheresis, including the use of genetic information to guide therapy and optimize outcomes for individual patients.
  3. Artificial Intelligence and Automation:
    Emerging research is focusing on the application of artificial intelligence and automation in transfusion medicine, aiming to enhance efficiency, safety, and decision-making in clinical practice.
  4. Ethical and Policy Considerations:
    A growing body of work addresses the ethical implications and policy considerations surrounding blood donation, transfusion practices, and patient consent, reflecting an increased awareness of social responsibility in healthcare.
  5. Innovations in Apheresis Techniques:
    An uptick in studies related to novel apheresis techniques and their applications in various medical conditions, suggesting a trend towards more specialized and effective treatment modalities.

Declining or Waning

As the field of transfusion medicine evolves, certain themes and topics have seen a decline in focus within recent publications. This reflects shifts in research priorities and emerging challenges in the field.
  1. Traditional Transfusion Practices:
    There is a noticeable decrease in studies centered around conventional blood transfusion practices as research increasingly emphasizes evidence-based practices and innovative solutions to transfusion-related challenges.
  2. Infectious Disease Transmission:
    Research on infectious disease transmission through blood transfusion has diminished as advancements in screening and pathogen reduction technologies have led to improved safety measures.
  3. Surgical Transfusion Protocols:
    Fewer articles are appearing on transfusion protocols specific to surgical settings, possibly due to evolving practices that focus more on patient blood management strategies rather than traditional protocols.
  4. Non-therapeutic Apheresis Applications:
    Research exploring non-therapeutic applications of apheresis has declined, as the focus shifts towards more clinically relevant uses, such as therapeutic plasma exchange and stem cell collection.

Similar Journals

Transfusionsmedizin

Innovating blood transfusion practices through research.
Publisher: GEORG THIEME VERLAG KGISSN: 2191-8805Frequency: 4 issues/year

Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.

Clinical Laboratory

Empowering Research for Modern Diagnostics
Publisher: CLIN LAB PUBLISSN: 1433-6510Frequency: 12 issues/year

Clinical Laboratory is a reputable journal dedicated to the interdisciplinary field of clinical biochemistry, genetics, and molecular biology. Published by CLIN LAB PUBL in Germany, this journal provides a platform for the dissemination of original research, reviews, and key insights into laboratory practices and innovations that play a crucial role in modern medicine and diagnostics. With an ISSN of 1433-6510 and a consistent publication history since its inception in 1964 and converging through 2024, it is indexed within the Scopus database, ranking in the 30th percentile among its peers. Although classified in the third quartile for 2023 in the field, Clinical Laboratory continues to contribute valuable knowledge and fosters collaboration among researchers, professionals, and students. Notably, it does not currently operate as an Open Access journal, which emphasizes its commitment to maintaining high-quality peer-reviewed content accessible through institutional and library subscriptions. For those in the domain, Clinical Laboratory serves as a vital resource for the latest advancements and trends shaping the future of clinical laboratory science.

Hematology Transfusion and Cell Therapy

Pioneering insights in hematology and transfusion care.
Publisher: ELSEVIERISSN: 2531-1379Frequency: 4 issues/year

Hematology Transfusion and Cell Therapy, published by Elsevier, is a leading Open Access journal dedicated to advancing the fields of hematology, immunology, and transfusion medicine. Since its establishment in 2018, this journal has provided a vital platform for sharing innovative research and clinical advancements in the management of blood disorders and cellular therapies. Based in Brazil, it attracts a global audience, facilitating access to high-quality research that influences clinical practice and policy. With a current impact factor that places it in the Q3 category for both hematology and immunology as of 2023, the journal is recognized for its rigorous peer-review process and commitment to disseminating significant findings. By featuring a diverse range of articles, from original research to reviews, Hematology Transfusion and Cell Therapy aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike, empowering them to tackle emerging challenges in their fields.

TRANSFUSION CLINIQUE ET BIOLOGIQUE

Advancing transfusion science for better patient outcomes.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 1246-7820Frequency: 4 issues/year

TRANSFUSION CLINIQUE ET BIOLOGIQUE, an esteemed journal published by Elsevier France - Éditions Scientifiques Médicales Elsevier, has been a pivotal resource in the fields of transfusion medicine, biochemistry, and hematology since its inception in 1994. With a strong commitment to advancing scientific knowledge, this journal provides a platform for high-quality research and clinical studies aimed at improving patient care and outcomes in transfusion practices. Although categorized in Q3 and Q4 quartiles across multiple categories in Biochemistry and Medicine for 2023, the journal holds significant potential for growth and impact within the scientific community. While it currently does not offer open access options, its indexing in reputable databases ensures visibility and reach among professionals and researchers. As the field evolves, TRANSFUSION CLINIQUE ET BIOLOGIQUE aims to continue fostering innovation and collaboration, making it a valuable tool for anyone involved in medical, biochemical, and hematological research.

Hematology

Empowering Research: Your Gateway to Hematology Excellence
Publisher: TAYLOR & FRANCIS LTDISSN: 1024-5332Frequency: 1 issue/year

Hematology is a distinguished open-access journal published by Taylor & Francis Ltd, dedicated to advancing research and knowledge in the field of hematology. Established in 1996, the journal has continually evolved to meet the needs of a growing community of researchers and practitioners, providing a vital platform for disseminating innovative findings and clinical insights. With its impact factor reflecting a robust commitment to quality scholarship, Hematology has achieved a respectable position in its category as evidenced by its Q3 ranking in the Hematology category and ranks #85 out of 137 in the Scopus index, which positions it in the 38th percentile among its peers. The journal’s open-access policy, initiated in 2019, further enhances its reach and accessibility, allowing a broad audience of professionals, researchers, and students to engage with high-quality research without barriers. By covering a wide range of topics related to blood disorders, treatment methodologies, and emerging therapies, Hematology stands as an essential resource for those dedicated to innovation in this critical area of healthcare.

AMERICAN JOURNAL OF HEMATOLOGY

Connecting Scholars to Shape the Future of Hematology
Publisher: WILEYISSN: 0361-8609Frequency: 12 issues/year

American Journal of Hematology, published by Wiley, stands as a premier outlet for the dissemination of cutting-edge research in the field of hematology. With a commendable impact factor and ranked #9 out of 137 in the Scopus medicine category, this journal has established a robust presence since its inception in 1976. Operating in the Q1 quartile for hematology, it serves as a crucial resource for researchers, clinicians, and students dedicated to understanding blood disorders and advancing treatment methodologies. While the journal does not currently offer open access options, it remains highly regarded for its rigorous peer-review process and impactful contributions to the scientific community. With coverage extending into 2024, the American Journal of Hematology is committed to fostering innovation and collaboration within the hematological sciences.

TRANSFUSION

Exploring New Frontiers in Blood Donation and Transfusion
Publisher: WILEYISSN: 0041-1132Frequency: 12 issues/year

TRANSFUSION is a prestigious peer-reviewed journal published by WILEY, dedicated to advancing the field of hematology and transfusion medicine. With an ISSN of 0041-1132 and an E-ISSN of 1537-2995, this journal serves as a vital resource for researchers and professionals alike, delivering high-quality studies and reviews that impact clinical practice and blood management strategies. The journal enjoys a strong reputation, evidenced by its impressive Q1 ranking in hematology and Q2 in both immunology and allergy as of 2023. Covering foundational aspects from 1958 to 2024, TRANSFUSION not only provides valuable insights but also fosters collaboration and innovation in understanding the complexities of blood donation, transfusion practices, and immunological responses. With its significant contributions to the scientific community, this journal is essential for those seeking to stay at the forefront of research and advancements in transfusion science.

Hematology-American Society of Hematology Education Program

Fostering Excellence in Hematological Research
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

TRANSFUSION MEDICINE REVIEWS

Unlocking insights in transfusion science.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-7963Frequency: 4 issues/year

TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.

Asian Journal of Transfusion Science

Advancing transfusion science for a healthier tomorrow.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0973-6247Frequency: 2 issues/year

Asian Journal of Transfusion Science, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a prominent open-access journal dedicated to the interdisciplinary fields of hematology and immunology. With an ISSN of 0973-6247 and E-ISSN 1998-3565, it serves as a crucial platform for researchers, clinicians, and students from around the globe, facilitating the dissemination of high-quality, peer-reviewed research. Established in 2007, the journal has consistently aimed to advance scientific knowledge in transfusion practices, enhancing patient care and safety in transfusion medicine. Despite its recent categorization in the Q4 quartile within both Hematology and Immunology, the journal is making strides toward greater visibility in the academic community, with plans for expanded reach and increased citation impact. With its commitment to open-access publishing, the Asian Journal of Transfusion Science ensures that invaluable research findings are readily accessible to all stakeholders, thereby bolstering collaborative efforts in transfusion science and related disciplines.